You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Kinetic Phenotype Discovery Informatics for Neurological Diseases
SBC: DRVISION TECHNOLOGIES LLC Topic: 101Project Summary Neurological disorders significantly outnumber diseases in other therapeutic areas and are growing in incidence faster than any other disease classesHoweverthe pharmaceutical industry has been unsuccessful in coming up with effective drugsA big factor in these failures has been a lack of adequate model systems for fundamental disease understanding affecting both diagnosis and treat ...
SBIR Phase II 2017 Department of Health and Human ServicesNational Institutes of Health -
Enabling point-of-care molecular diagnostics by developing an adaptive PCR instrument and on-demand kit reagents
SBC: BIOVENTURES, INC Topic: 172Because of its high sensitivitypolymerase chain reactionPCRis the gold standard for the diagnosis of many infectious diseasesbut generally only implemented in well equipped laboratoriesOne of the major roadblocks for expanding PCR to point of care markets is the lack of simplerobustsingle tube PCR designs which preserve its laboratory based high sensitivity and specificityIn this Fast Track STTR a ...
STTR Phase II 2017 Department of Health and Human ServicesNational Institutes of Health -
Lithium Oxyhalide Battery Separator Material
SBC: ESPIN TECHNOLOGIES, INC. Topic: MDA15027eSpin Technologies will design the scale up machine to produce novel high performance separator for lithium primary batteries. The process will be developed to produce novel separator and a variants which has the potential of a significantly higher volumetric efficiency for electrolyte storage capacity and kinetics to distribute electrolyte flow within nanoporous channel efficiently. This new sepa ...
SBIR Phase II 2017 Department of DefenseMissile Defense Agency -
Development of Chemistry, Manufacturing, and Control Standards for PGC and PGC-dANP
SBC: PHARMAIN CORPORATION Topic: NHLBIABSTRACTThis application is seeking funding specifically for ChemistryManufacturingand ControlCMCof scale up production of long acting atrial natriuretic peptidedANPand its protected graft co polymerPGCexcipient for use in heart failureHFtreatmentThe extrinsic merit of this project will be the availability of cGMP grade PGC for use in prolonging the half life of various peptide drugs that are in p ...
SBIR Phase II 2017 Department of Health and Human ServicesNational Institutes of Health -
PREDICTIVE BIOMARKERS OF ADVERSE REACTIONS TO PROSTRATE CANCER RADIOTHERAPY
SBC: L2 DIAGNOSTICS LLC Topic: NCIThe overall objective of this project is to advance the development of a clinically usefully multiplex assay todetect biomarkers of radio sensitivity that will identify subsets of prostate cancer patients for whichradiotherapy should be contraindicated This assay will be capable of predicting the risk of developingadverse effects principally urinary morbidity and rectal injury resulting from ...
SBIR Phase II 2017 Department of Health and Human ServicesNational Institutes of Health -
A Novel Tolerance Therapeutic for Treating Multiple Sclerosis
SBC: VIRTICI LLC Topic: NIAIDOur goal is to develop VTC MSas a novel tolerance inducing therapeutic to treat Multiple SclerosisMSMS is the most common demyelinating disorder of the Central Nervous SystemCNSaffecting approximatelymillion people worldwide andin the US aloneCurrent and developing treatment of MS relies mainly on immuno suppression and modulation to reduce inflammatory symptoms creating a significant need for new ...
SBIR Phase II 2017 Department of Health and Human ServicesNational Institutes of Health -
Development of an Open Speech Signal Processing Platform
SBC: SensorLogic, Inc. Topic: NIDCDThis proposal will create an open speech signal processing platform. The open computational framework will be used for developing algorithms that will help accelerate acoustic and hearing science research. It will permit researchers to more rapidly and easily test new algorithms with greater control, performance, and ease. Several example systems will be created to show that the platform can be ad ...
SBIR Phase II 2017 Department of Health and Human ServicesNational Institutes of Health -
A single-cell device to capture and analyze rare T-cells from solid tumors.
SBC: ISOPLEXIS CORPORATION Topic: 102Checkpoint inhibitors towards targets such as PDand PD Lare being developed to activate quiescent T cells embedded in tumors and enable them to recruit the rest of the immune system to fight a cancer massHow these new cures reactivate the relatively few Tumor Infiltrating LymphocytesTILsenabling the release of a complex message of cytokines to recruit the immune systemthus impacting treatment effi ...
SBIR Phase II 2017 Department of Health and Human ServicesNational Institutes of Health -
Precision quality check of immunotherapeutics via single-cell cytokine mapping
SBC: ISOPLEXIS CORPORATION Topic: 102Adoptive transfer of autologous T cells engineered to express chimeric antigen receptorsCARshas emerged as a promising immunotherapy for patients with hematologic malignanciessuch as CDCARs in leukemias and lymphomasHoweverchallenges remain in terms of manufacturing consistency and the functional profile of the CAR T cell productsince infused cellsasliving drugscan be activated and release a varie ...
SBIR Phase II 2017 Department of Health and Human ServicesNational Institutes of Health -
A Novel Peptide Therapeutic for Obesity
SBC: VIRTICI LLC Topic: 300Project Summary The goal of this project is to develop a novel peptide therapeuticVTC Gfor the treatment of obesityTodayone third of adults in the United StatesUSare obesewith an estimated annual healthcare burden of approximately $billionByit is projected that overof adults in the US will be obese with a yearly healthcare burden expected to exceed $billionwhich will account for approximatelyof th ...
SBIR Phase II 2017 Department of Health and Human ServicesNational Institutes of Health